|Articles|April 2, 2022

Pharmaceutical Technology

  • Pharmaceutical Technology, April 2022
  • Volume 46
  • Issue 4
  • Pages: 12

Modular Liquid Processing Systems

The PureVessel series provides modular storage, preparation, treatment, and mixing of liquids.

Suncombe’s PureVessel range of systems are designed for sanitary and sterile liquid storage, preparation, thermal treatment, and mixing in laboratories and research institutes. They have been developed to operate within a hybrid bioprocessing model, wherein a processing facility employs a combination of single-use technologies and stainless-steel multi-use equipment.

Available in capacities from 10 to 300 liters, PureVessels are modular and can be equipped with top entry agitators, bottom mounted magnetic mixers, heating and cooling jackets, spray devices, and instruments, and can be mounted on load cells. The units are constructed from 316 stainless steel and Hastelloy for chlorine resistance.

The series operates with either the Suncombe PureCIP or MobileCIP. To provide a pre-validated clean-in-place/sterilize-in-place cycle, every PureVessel can be “plugged” into the automation system, allowing the CIP/SIP to recognize the PureVessel being cleaned and select the optimum cycle for each vessel. All products are certified for ASME and ISQ/EN standards for processing biopharmaceutical products.

Suncombe
www.suncombe.eu


Related to this article

CPHI Milan 2026: Nitrosamine Risk Mitigation, Part 2
Mitigating nitrosamine risk requires assessing each product individually, says Bram Baert, Global Head of Regulatory Affairs at Capsugel, and Sandrine Picco, Senior Analytical Specialist on Capsugel's Innovaform Accelerator Team, in this interview with PharmTech.
Trophy and confetti on light background, top view with space for text. Victory concept | Image Credit: ©New Africa -stock.adobe.com
The winners of the CPHI Pharma Awards 2026 include a neurodegeneration platform, a track-and-trace packaging innovation, a enzymatic mRNA manufacturing technology, and a cell-free enzymatic biomanufacturing platform.
PharmTech Weekly Roundup—October 2, 2026
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.